Insider Buying: Crescita Therapeutics Inc. (TSE:CTX) Director Acquires 86,000 Shares of Stock

Crescita Therapeutics Inc. (TSE:CTX) Director Jose Darocha acquired 86,000 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was acquired at an average price of C$0.60 per share, for a total transaction of C$51,436.60.

Crescita Therapeutics Stock Performance

Shares of Crescita Therapeutics stock opened at C$0.60 on Monday. The firm has a fifty day moving average of C$0.58 and a two-hundred day moving average of C$0.58. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The stock has a market capitalization of C$11.63 million, a price-to-earnings ratio of -4.00 and a beta of 1.69. Crescita Therapeutics Inc. has a 52 week low of C$0.36 and a 52 week high of C$0.69.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.